Table 4.
Cytopathological results for the Osaka Medical College (OMC) system for each final pathology.
| 1-1 | 1-2 | 2 | 3 | 4-1 | 4-2 | 5 | 6-1 | 6-2 | 6-3 | 6-4 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Malignant | ||||||||||||
| MEC | 8 (6/2) |
1 (1/0) |
3 (2/1) |
0 |
2 (1/1) |
3 (3/0) |
7 (4/3) |
4 (3/1) |
3 (1/2) |
3 (1/2) |
17 (4/13) |
51 |
| Ca ex pleo |
2 (1/1) |
4 (2/2) |
3 (3/0) |
3 (0/3) |
1 (0/1) |
6 (2/4) |
4 (1/3) |
6 (2/4) |
29 | |||
| AdCC | 3 (2/1) |
1 (1/0) |
2 (2/0) |
3 (3/0) |
1 (1/0) |
3 (0/3) |
9 (8/1) |
22 | ||||
| SDC | 1 | 1 | 1 | 8 | 7 | 18 | ||||||
| Benign | ||||||||||||
| Pleo | 40 | 3 | 7 | 3 | 515 | 16 | 12 | 2 | 3 | 1 | 3 | 605 |
| Warthin | 39 | 2 | 10 | 3 | 166 | 6 | 3 | 1 | 225 | |||
| BCA | 11 | 21 | 11 | 3 | 1 | 47 |
The number in parentheses indicates each case by histological grade (low- or intermediate-/high-grade). AdCC, adenoid cystic carcinoma; BCA, basal cell adenoma; Ca ex pleo, carcinoma ex pleomorphic adenoma; MEC, mucoepidermoid carcinoma; Pleo, pleomorphic adenoma; SDC, salivary duct carcinoma; Warthin, Warthin tumor.